| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12020-009-9157-3 |
| P698 | PubMed publication ID | 19259830 |
| P50 | author | Kubilay Ukinç | Q73341692 |
| P2093 | author name string | Cihangir Erem | |
| Halil Onder Ersoz | |||
| Suleyman Sami Karti | |||
| Arif Bayram Hacihasanoglu | |||
| P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| Ferritin: a cytoprotective antioxidant strategem of endothelium | Q28264360 | ||
| Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes | Q28278731 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Coronary heart disease and iron status: meta-analyses of prospective studies | Q33535333 | ||
| Evaluating novel cardiovascular risk factors: can we better predict heart attacks? | Q33664550 | ||
| Inflammation markers and coronary heart disease | Q33770537 | ||
| C-reactive protein, inflammation, and coronary risk | Q33843636 | ||
| MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial | Q33966645 | ||
| Simvastatin in severe hypercholesterolaemia: a placebo controlled trial | Q34358043 | ||
| Dyslipidaemia and coagulation defects of insulin resistance. | Q34608920 | ||
| Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro | Q35798405 | ||
| Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study | Q36246409 | ||
| Is atorvastatin superior to other statins? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints | Q37161160 | ||
| Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study | Q40678166 | ||
| Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature | Q40904739 | ||
| Fenton chemistry: an introduction. | Q40980956 | ||
| Iron and the sex difference in heart disease risk | Q41531831 | ||
| Lipid peroxides and atherosclerosis | Q43379861 | ||
| Ferritin and superoxide-dependent lipid peroxidation | Q43608908 | ||
| Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease | Q43614603 | ||
| Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events | Q43656468 | ||
| Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death | Q43935480 | ||
| Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications | Q45193883 | ||
| Fibrinogen is an independent marker for thoracic aortic atherosclerosis. | Q50907848 | ||
| Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus. | Q50995281 | ||
| Plasma fibrinogen in NIDDM: the Rotterdam study. | Q51021585 | ||
| Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. | Q51552694 | ||
| Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. | Q51553762 | ||
| Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group. | Q51576971 | ||
| Nitric oxide mediates iron release from ferritin. | Q52483617 | ||
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia. | Q53931120 | ||
| Low density lipoprotein oxidation by stimulated neutrophils and ferritin | Q67508044 | ||
| Serum ferritin as a measure of iron stores in normal subjects | Q68926287 | ||
| Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 | ||
| Fibrinogen, coronary heart disease and mortality from all causes in smokers and nonsmokers. The study of men born in 1933 | Q71132026 | ||
| Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? | Q72648151 | ||
| Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo | Q72767066 | ||
| Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) | Q73209707 | ||
| Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations | Q74352479 | ||
| More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia | Q77366656 | ||
| The electrocardiogram in population studies. A classification system | Q79313316 | ||
| P433 | issue | 3 | |
| P921 | main subject | simvastatin | Q670131 |
| P304 | page(s) | 380-388 | |
| P577 | publication date | 2009-03-04 | |
| P1433 | published in | Endocrine | Q15757048 |
| P1476 | title | Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients | |
| P478 | volume | 35 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q51388945 | Anti‐Inflammatory and Monocyte‐Suppressing Effects of Simvastatin in Patients with Impaired Fasting Glucose |
| Q93184651 | Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study |
| Q24634840 | Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients |
| Q37898699 | Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia |
| Q86118577 | The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention |
Search more.